SpringWorks Therapeutics Cash from Financing (TTM) Analysis

SpringWorks Therapeutics Inc (SWTX)

44.00 +1.08 (+2.52%) USD | NASDAQ | Apr 23, 16:00

44.00 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	296.64M
September 30, 2023	-2.134M
June 30, 2023	338.34M
March 31, 2023	338.59M
December 31, 2022	340.70M
September 30, 2022	340.65M
June 30, 2022	0.842M
March 31, 2022	1.059M
December 31, 2021	1.157M

Date	Value
September 30, 2021	270.89M
June 30, 2021	270.89M
March 31, 2021	270.84M
December 31, 2020	270.48M
September 30, 2020	0.532M
June 30, 2020	169.84M
March 31, 2020	169.76M
December 31, 2019	333.71M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-2.134M

Minimum

Sep 2023

340.70M

Maximum

Dec 2022

200.75M

Average

270.84M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks